It adds a layer of direct fat mobilization that compounds targeting appetite and metabolism from other angles cannot replicate on their own
It is a small investment in adaptation that pays dividends in comfort, adherence, and ultimately results throughout the remaining 90% of the protocol
Certain formulations have separate FDA approvals for chronic weight management (Wegovy, Saxenda, Zepbound), with higher-dose semaglutide and tirzepatide capable of producing 1015% weight reduction, while other GLP-1 agents typically yield more modest weight loss
Within the overall category of GLP-1s, you have multiple options, including semaglutide, with the brand names Wegovy and Ozempic, and tirzepatide, with the brand names Mounjaro and Zepbound
GLP-1 agonists act like this hormone, helping to control blood sugar levels